Glassman Wealth Services Moderna, Inc. Transaction History

Glassman Wealth Services

$585 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $17,447 - $26,211	-251 Reduced 65.54%	132 $13,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $4,434 - $5,824	46 Added 13.65%	383 $39,000
Q2 2023 Aug 08, 2023	BUY	$118.5 - $160.53 $11,257 - $15,250	95 Added 39.26%	337 $40,000
Q1 2023 May 04, 2023	SELL	$135.66 - $197.02 $17,364 - $25,218	-128 Reduced 34.59%	242 $37,000
Q4 2022 Feb 06, 2023	BUY	$118.38 - $210.04 $15,389 - $27,305	130 Added 54.17%	370 $66,000
Q3 2022 Nov 09, 2022	SELL	$118.07 - $194.18 $11,807 - $19,418	-100 Reduced 29.41%	240 $28,000
Q2 2022 Aug 04, 2022	BUY	$117.13 - $176.59 $8,784 - $13,244	75 Added 28.3%	340 $49,000
Q1 2022 Aug 23, 2022	BUY	$126.46 - $235.05 $8,093 - $15,043	64 Added 31.84%	265 $46,000
Q1 2022 Apr 14, 2022	BUY	$126.46 - $235.05 $4,173 - $7,756	33 Added 19.64%	201 $35,000
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $43,357 - $70,753	-192 Reduced 53.33%	168 $43,000
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $9,541 - $20,832	43 Added 13.56%	360 $139,000
Q2 2021 Aug 04, 2021	BUY	$129.91 - $234.98 $1,299 - $2,349	10 Added 3.26%	317 $74,000
Q1 2021 May 05, 2021	BUY	$109.18 - $185.98 $4,694 - $7,997	43 Added 16.29%	307 $40,000
Q4 2020 Feb 04, 2021	BUY	$65.74 - $169.86 $3,418 - $8,832	52 Added 24.53%	264 $28,000
Q3 2020 Nov 09, 2020	BUY	$54.34 - $94.85 $1,901 - $3,319	35 Added 19.77%	212 $15,000
Q2 2020 Aug 06, 2020	BUY	$29.67 - $80.0 $1,809 - $4,880	61 Added 52.59%	177 $11,000
Q1 2020 May 12, 2020	BUY	$17.78 - $31.58 $2,062 - $3,663	116 New	116 $3,000
Q3 2019 Nov 01, 2019	SELL	$12.26 - $18.07 $159 - $234	-13 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$13.7 - $28.34 $178 - $368	13 New	13 $0

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.

Account